Skip to main content

Advertisement

SpringerLink
Log in

Opioid misuse in oncology pain patients

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

The problem of therapeutic opioid misuse largely affects patients who need opioids to treat chronic pain conditions. Opioid misuse is rarely an overt clinical problem during end of life or acute pain treatment. Misuse attaches a stigma to opioid use, and makes many patients and prescribers reluctant to use these uniquely effective drugs, even when misuse is unlikely. Cancer was once an explosive, typically terminal disease and became the prototype for end-of-life opioid pain treatment. However, cancer is no longer such an explosive disease, and many cancer sufferers can now expect to have a prolonged, even normal, lifespan. They may need pain treatment, but this treatment should not be modeled on palliative care paradigms. This article describes the underlying mechanisms of opioid dependence and its progression to addiction, and suggests a cautious approach to opioid treatment of chronic cancer pain that aims to minimize the problem of misuse.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References and Recommended Reading

  1. Nestler E: Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001, 2:119–128.

    Article  PubMed  CAS  Google Scholar 

  2. Cami J, Farre M: Drug addiction. N Engl J Med 2003, 349:975–986.

    Article  PubMed  CAS  Google Scholar 

  3. Johnson S, North R: Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992, 12:483–488.

    PubMed  CAS  Google Scholar 

  4. Bonci A, Williams J: Increased probability of GABA release during withdrawal from morphine. J Neurosci 1997, 17:796–803.

    PubMed  CAS  Google Scholar 

  5. Hyman S, Malenka R: Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001, 2:695–703.

    Article  PubMed  CAS  Google Scholar 

  6. Nestler E: Under siege: the brain on opiates. Neuron 1996, 16:897–900.

    Article  PubMed  CAS  Google Scholar 

  7. Wise R: Addiction becomes a brain disease. Neuron 2000, 26:27–33.

    Article  PubMed  CAS  Google Scholar 

  8. Koob G, Le Moal M: Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97–129.

    Article  PubMed  CAS  Google Scholar 

  9. Koob G, Le Moal M: Drug abuse: hedonic homeostatic dysregulation. Science 1997, 278:52–58.

    Article  PubMed  CAS  Google Scholar 

  10. Sell L, Morris J, Bearn J, et al.: Activation of reward circuitry in human opiate addicts. Eur J Neurosci 1999, 11:1042–1048.

    Article  PubMed  CAS  Google Scholar 

  11. Childress A, McLellan A, O’Brien C: Conditioned responses in a methadone population. J Subst Abuse Treat 1986, 3:173–179.

    Article  PubMed  CAS  Google Scholar 

  12. Narita M, Funada M, Suzuki T: Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 2001, 89:1–15.

    Article  PubMed  CAS  Google Scholar 

  13. Self D, Nestler E: Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend 1998, 51:49–60.

    Article  PubMed  CAS  Google Scholar 

  14. Robinson T, Berridge K: The neural incentive basis of drug craving: an incentive sensitization theory of addiction. Brain Res Rev 1993, 18:247–291.

    Article  PubMed  CAS  Google Scholar 

  15. Morris J, Friston K, Dolan R: Neural responses to salient visual stimuli. Proc R Soc Lond B Biol Sci 1997, 264:769–775.

    Article  CAS  Google Scholar 

  16. O’Brien CP, Childress AR, Ehrman R, Robbins SJ: Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol 1998, 12:15–22.

    Article  PubMed  CAS  Google Scholar 

  17. Shaham Y, Erb S, Stewart J: Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev 2000, 33:13–33.

    Article  PubMed  CAS  Google Scholar 

  18. Kreek MJ: Drug addictions: molecular and cellular endpoints. Ann N Y Acad Sci 2001, 937:27–49.

    Article  PubMed  CAS  Google Scholar 

  19. Hyman S: Dispelling the Myths About Addiction. Washington, DC: Institute of Medicine, National Academy of Sciences Press; 1997:44–46.

    Google Scholar 

  20. Savage SR: Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage 1996, 11:274–286.

    Article  PubMed  CAS  Google Scholar 

  21. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.

    Google Scholar 

  22. Hyman SE, Malenka RC, Nestler EJ: Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006, 29:565–598.

    Article  PubMed  CAS  Google Scholar 

  23. Chabal C, Erjavec M, Jacobson L, et al.: Prescription opiate abuse in chronic pain patients: clinical criteria, incidence and predictors. Clin J Pain 1997, 13:150–155.

    Article  PubMed  CAS  Google Scholar 

  24. Portenoy RK, Foley KM: Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986, 25:171–186.

    Article  PubMed  CAS  Google Scholar 

  25. Fishbain D, Rosomoff H, Rosomoff R: Drug abuse, dependence and addiction in chronic pain patients. Clin J Pain 1992, 8:77–85.

    Article  PubMed  CAS  Google Scholar 

  26. Hojsted J, Sjogren P: Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2006, 11:490–518.

    Article  PubMed  CAS  Google Scholar 

  27. Martell BA, O’Connor PG, Kerns RD, et al.: Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007, 146:116–127.

    PubMed  Google Scholar 

  28. Elander J, Lusher J, Bevan D, Telfer P: Pain management and symptoms of substance dependence among patients with sickle cell disease. Soc Sci Med 2003, 57:1683–1696.

    Article  PubMed  Google Scholar 

  29. Portenoy RK: Opioid therapy for chronic nonnalignant pain: a review of the critical issues. J Pain Symptom Manage 1996, 11:203–217.

    Article  PubMed  CAS  Google Scholar 

  30. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997, 13:6–8.

  31. The Federation of State Medical Boards of the United States, Inc. Model guidelines for the use of controlled substances for the treatment of pain. S D J Med 1999, 52:25–27.

    Google Scholar 

  32. The College of Physicians and Surgeons of Ontario: Evidence-based recommendations for medical management of chronic non-malignant pain: reference guide for clinicians. http://www.cpso.on.ca/publications/pain.htm. Accessed May 23, 2007.

  33. Collett BJ: Chronic opioid therapy for non-cancer pain. Br J Anaesth 2001, 87:133–144.

    Article  PubMed  CAS  Google Scholar 

  34. Kalso E, Allan L, Dellemijn P, et al.: Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003, 7:381–386.

    Article  PubMed  CAS  Google Scholar 

  35. Atluri S, Boswell MV, Hansen HC, et al.: Guidelines for the use of controlled substances in the management of chronic pain. Pain Physician 2003, 6:233–257.

    PubMed  Google Scholar 

  36. Ballantyne J, Mao J: Opioid therapy for chronic pain. N Engl J Med 2003, 349:1943–1953.

    Article  PubMed  CAS  Google Scholar 

  37. Jovey R, Ennis J, Gardner-Nix J, et al.: Use of opioid analgesics for the treatment of chronic noncancer pain—a consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Res Manag 2003, 8(Suppl A):3A–28A.

    PubMed  Google Scholar 

  38. The British Pain Society: Recommendations for the appropriate use of opioids for persistent non-cancer pain. A consensus statement prepared on behalf of the British Pain Society, the Royal College of Anaesthetists, the Royal College of General Practitioners, and the Royal College of Psychiatrists. http://www.britishpainsociety.org/opioids_doc_2004.pdf. Accessed May 23, 2007.

  39. VA/DoD Clinical Practice Guideline for the Management of Opioid Therapy for Chronic Pain. http://www.oqp.med.va.gov?cpg/cpg.htm. Accessed October 24, 2006.

  40. Compton P, Darakjian J, Miotto K: Screening for addiction in patients with chronic pain with “problematic” substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage 1998, 16:355–363.

    Article  PubMed  CAS  Google Scholar 

  41. Passik SD, Kirsh KL, Whitcomb L, et al.: A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther 2004, 26:552–561.

    Article  PubMed  CAS  Google Scholar 

  42. Adams L, Gatchel R, Robinson RC, et al.: Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage 2004, 27:440–459.

    Article  PubMed  Google Scholar 

  43. Butler S, Budman S, Fernandez K, Jamison R: Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004, 112:65–75.

    Article  PubMed  CAS  Google Scholar 

  44. Belgrade MJ, Schamber CD, Lindgren BR: The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain 2006, 7:671–681.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Massachusetts General Hospital, Division of Pain Medicine, 15 Parkman Street, WACC 333, Boston, MA, 02114, USA

    Jane C. Ballantyne MD

Authors
  1. Jane C. Ballantyne MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jane C. Ballantyne MD.

About this article

Cite this article

Ballantyne, J.C. Opioid misuse in oncology pain patients. Current Science Inc 11, 276–282 (2007). https://doi.org/10.1007/s11916-007-0204-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-007-0204-6

Keywords

Search

Navigation